SRDX Stock Recent News

SRDX LATEST HEADLINES

SRDX Stock News Image - zacks.com

SurModics (SRDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

zacks.com 2025 Jan 14
SRDX Stock News Image - zacks.com

SurModics (SRDX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com 2025 Jan 03
SRDX Stock News Image - zacks.com

SRDX and CWAN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 3, 2024.

zacks.com 2025 Jan 03
SRDX Stock News Image - zacks.com

UAA, BRBR, RBA, SRDX and CTRA have been added to the Zacks Rank #1 (Strong Buy) List on January 3, 2024.

zacks.com 2025 Jan 03
SRDX Stock News Image - zacks.com

Surmodics' latest regulatory achievement is likely to broaden the platform's clinical utility and significantly expand its addressable market.

zacks.com 2024 Oct 02
SRDX Stock News Image - zacks.com

SurModics (SRDX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

zacks.com 2024 Sep 06
SRDX Stock News Image - zacks.com

SurModics (SRDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

zacks.com 2024 Sep 05
SRDX Stock News Image - zacks.com

SurModics (SRDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

zacks.com 2024 Aug 15
SRDX Stock News Image - zacks.com

Although the revenue and EPS for SurModics (SRDX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com 2024 Jul 31
SRDX Stock News Image - zacks.com

SurModics (SRDX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to earnings of $0.52 per share a year ago.

zacks.com 2024 Jul 31
10 of 50